Biotech

All Articles

Basilea credit ratings $268M BARDA financing for antifungals, anti-biotics

.Basilea Pharmaceutica's work creating new antifungals has gotten a notable increase coming from the...

Capricor sells Europe liberties to late-stage DMD therapy for $35M

.Having currently scooped up the USA legal rights to Capricor Therapeutics' late-stage Duchenne musc...

FDA junks adcomm for Applied's uncommon health condition drug

.After pushing back the decision meeting for Applied Rehabs' metabolic disorder medication govoresta...

Novo inks $600M NanoVation offer to study genetic medications ex-liver

.Novo Nordisk is continuing its own press in to genetic medicines, agreeing to compensate NanoVation...

Innovent links cytokine to colorectal cancer cells reactions

.Innovent Biologics has actually produced the scenario that its checkpoint inhibitor-cytokine blend ...

Merck, Daiichi ADC strikes target in stage 3 lung cancer cells research study

.A period 3 test of Daiichi Sankyo and Merck &amp Co.'s HER3-directed antibody-drug conjugate (ADC) ...

Rakovina deepens artificial intelligence center with collab to select cancer cells aim ats

.Five months after Rakovina Rehabs turned toward expert system, the cancer-focused biotech has actua...

Ascendis' dwarfism drug smash hits in phase 3, intimidates BioMarin

.Ascendis Pharma has actually emerged as a potential risk to BioMarin's Voxzogo, disclosing period 3...

Despite ph. 3 overlook, Alkeus finds path ahead for eye health condition property

.Though Alkeus Pharmaceuticals' oral eye ailment asset fell short to significantly lower geographic ...

Kairos goes social with $6M IPO to money trials of cancer cells medication

.Along with a trio of biotechs striking the Nasdaq on Friday, it was quick and easy to miss a smalle...